Background {#Sec1}
==========

Melanopsin-expressing, intrinsically photosensitive retinal ganglion cells (ipRGCs) represent a class of non-canonical, ganglion cell photoreceptors. These cells influence a variety of visual behaviors including contrast sensitivity \[[@CR1]\], circadian photoentrainment \[[@CR2]--[@CR4]\], sleep \[[@CR5], [@CR6]\], and even mood \[[@CR7], [@CR8]\]. These wide-ranging behavioral influences are attributed to the multiple subtypes (M1--6) that comprise the ipRGC population, with different subtypes possessing a unique complement of cellular properties and playing distinct roles in vision. For example, the M1 ipRGC subtype has been linked to subconscious, non-image forming behaviors including circadian photoentrainment, the pupillary light reflex, and even regulation of mood and learning. The M4 ipRGCs, in comparison, are important for proper contrast sensitivity in visual perception \[[@CR1], [@CR9]\].

Although ipRGCs have been categorized based on their adult characteristics, they are in fact light sensitive from embryonic stages \[[@CR10]--[@CR12]\] and begin to exhibit diverse light response properties at early postnatal stages \[[@CR13], [@CR14]\]. Thus, these unique photoreceptors are light sensitive long before the rest of the retinal circuitry is able to functionally relay rod/cone signals around \~P12 when the eyes open \[[@CR15], [@CR16]\]. This early photosensitivity has led to multiple studies examining potential developmental influences of ipRGCs on the developing retina and visual system. One study found that melanopsin modulates the branching patterns of retinal vasculature in a light-dependent manner \[[@CR10]\]. Other studies revealed that melanopsin and ipRGCs can influence spontaneous retinal waves \[[@CR17]\] and that they are important retinofugal refinement \[[@CR17], [@CR18]\]. Surprisingly, light and melanopsin can even drive a light avoidance behavior in neonatal mice as young as 6 days old \[[@CR19]\].

While it is clear that light is modulating retinal development and even pup behavior through melanopsin, the circuit mechanisms of these effects remain unclear. In particular, it is not known which of the six ipRGC subtypes mediate these developmental effects. A first step in determining the role of the ipRGC subtypes in development is characterizing the developmental time course of the maturation of each cell type. A previous study has revealed that there are at least three physiological ipRGC subtypes during development, type I, II, and III \[[@CR13]\]. These subtypes were differentiated based on the size and sensitivity of their light responses with follow up studies proposing that that the type I corresponds to the adult M4 subtype, type II to the M2 subtype, and type III to the M1 subtype \[[@CR14], [@CR20]\]. Beyond this, little is known about the structure and function of ipRGC subtypes during development, and yet this information is a necessary first step in understanding the mechanisms by which ipRGCs influence the developing retina. We therefore set out to characterize the morphology, physiology, and developmental "birth" date of the three major ipRGC subtypes, M1, M2, and M4. We found that ipRGC subtypes are differentiable at early postnatal stages and seem to exhibit different rates of maturation. Moreover, we find that while ipRGCs are generally born at similar embryonic time points, their birth is largely complete at timepoints earlier than two groups of conventional RGCs: the OFF alpha RGCs and Brn3a positive RGCs.

Methods {#Sec2}
=======

Animals {#Sec3}
-------

All procedures were approved by the Animal Care and Use Committee at Northwestern University. Both male and female mice were used and are from a mixed B6/129 background. Adult mice were between 30 and 60 days of age.

Electrophysiology {#Sec4}
-----------------

We used *Opn4-GFP* \[[@CR21]\] mice for all electrophysiological recordings. All mice P14 and under were dark adapted 1--2 h prior to recording. Adult mice were dark adapted overnight. Pups aged P10 and under were sacrificed via decapitation. P14 pups and adult mice were euthanized using CO~2~ asphyxiation followed by cervical dislocation under dim red illumination. Eyes were enucleated, and retina were dissected under dim red light in carbogenated (95% O~2~--5%CO~2~) Ames\' medium (Sigma, A1420). Retinas were then sliced in half and incubated at 25 °C in Ames\' solution for at least 30 min. Retinas were mounted ganglion side up on glass bottom recording chamber and anchored using a platinum ring with nylon mesh. Recordings were performed at 24--26 °C with 1-2 mL/min flow of Ames\' solution. ipRGCs (GFP positive) were visualized using whole field 480 nm light for less than 30 s at 3.5 × 10^17^ photons/cm^2^ s^− 1^ intensity, and so all properties of ipRGCs were measured in light adapted tissue. Note that all subtypes at all ages were exposed to similar amounts of light, so any effect of light adaptation should be similar across development and between subtypes. Adult M4 cells were targeted using their characteristic large somata and confirmed post-recording with immunohistochemistry and dendritic stratification.

Recording pipettes were between 4 and 8 MΩ and filled with following internal solution (in mM): 125 K-gluconate, 2 CaCl2, 2 MgCl2, 10 EGTA, 10 HEPES, 2 Na2-ATP, 0.5 Na-GTP, 10 μM Alexa Fluor hydrazide 488 (Thermo, A10436), and 0.3% neurobiotin (Vector, SP-1120-50), pH to 7.2 with KOH.

After recording, retina pieces were fixed with 4% PFA overnight at 4 °C. Pieces were then washed with PBS, blocked for 1 h in 0.3% Triton-X, 6% donkey serum at room temperature. After blocking, pieces were then placed in the following primary for 2 nights at 4 °C. On the third day, retina pieces were washed with PBS and placed into the following secondary solution for 2 h at room temperature in the dark. Retinas were then washed and mounted in fluoromount (Sigma, F4680). See Table [1](#Tab1){ref-type="table"} for specific antibodies and concentrations. All images were captured using a confocal laser scanning microscope (LSM, DFC 310 FX, Leica) with a 40x oil-immersion objective. Table 1Antibodies for ImmunohistochemistryGenotypePrimary SolutionSecondary Solution*Opn4-GFP* (post-recording pieces)Streptavidin 488 (Thermo, S11223), mouse anti-SMI32 (BioLegend, 801,701), goat anti-ChAT (Milipore, AB144P)Streptavidin 488, donkey anti-mouse (Thermo, A31571), donkey anti-goat (Thermo, A-11056)*Opn4* ^*Cre/+*^ *;ZEG*rabbit anti-GFP (Thermo, A11122), mouse anti-SMI32goat anti-rabbit (Thermo, A11034), goat anti-mouse (Thermo, A21125)*Opn4* ^*LacZ/+*^ *;Opn4-GFP*chicken anti-Beta galactosidase (Invitrogen, A11132), rabbit anti-GFPgoat anti-chicken (Thermo, SA172000), goat anti-rabbit (Thermo, A-11035)*Opn4*^*LacZ/+*^ & *Opn4*^*Cre/+*^Mouse anti-Brn3a (Milipore, MAB1585), goat anti-ChATDonkey anti-mouse, donkey anti-goatAll primary and secondary solutions are 0.3% Triton-X and 6% goat or donkey serum. With the exception of ChAT, all primary and matching secondary were done at 1:500 dilutions. ChAT and corresponding secondary were done at 1:250

Inner plexiform lamination analysis {#Sec5}
-----------------------------------

Dendritic arbors from ipRGCs were traced using Fiji plugin software, simple neurite tracer with subsequent analysis done by using a similar program and methods as described in Nath & Schwartz, 2016 \[[@CR22], [@CR23]\].

Morphological analysis {#Sec6}
----------------------

FIJI (ImageJ) software was used to analyze cell morphology. For soma diameter measurements, we took a DIC image of the soma before patching. Using the polygon tool, we traced the entire soma and calculated the diameter using the circle eq. A similar method was used to calculate dendritic diameter from cell fill images. We used FIJI plugin, neuronJ, to trace cell fills to get a measurement of total dendritic length. These traced cell fills were subsequently used for Sholl analysis which was performed using the FIJI software.

Electrophysiological analysis {#Sec7}
-----------------------------

### C~m~/R~inp~ {#Sec8}

Cells were given a 10 mV hyperpolarization step in voltage clamp mode. Capacitance and input resistance were calculated from recorded trace using Ohm's law.

### V~m~ {#Sec9}

Cells were recorded at rest in current clamp mode for 3 min with the last minute of the recording being averaged to yield the resting membrane potential. Spike frequency was also assessed in the last minute of the recording.

### Depolarizing current injections {#Sec10}

Current was injected to hold cells at − 79 mV and cells were then injected with 1 s of +10pA or + 20pA stepwise current until cells reached a current that caused depolarization block.

### Action potentials {#Sec11}

For action potential analysis, the first action potential elicited at the lowest depolarizing current was used for full width half maximum (from threshold), threshold \[[@CR24]\], and hyperpolarization analysis. Hyperpolarization was measured as the difference between the threshold and the lowest point following action potential peak.

### Light onset {#Sec12}

Light onset was defined when cell membrane potential reach 50% of maximum light response during the lights on period.

Statistics {#Sec13}
----------

Using Prism graphpad, we analyzed data with non-parametric one-way (Kruskal-Wallis) with Dunn's multiple comparisons test for any ANOVA that indicated statistical difference. Statistical significance was concluded when *p* \< 0.05.

Birthdating {#Sec14}
-----------

We crossed *Opn4*^*Cre/+*^;*ZEG* to Wildtype mice to generate *Opn4*^*Cre/+*^;*ZEG* animals and *Opn4*^*LacZ/LacZ*^ to *Opn4-GFP* to generate *Opn4*^*LacZ/+*^;*Opn4-GFP* mice. See Table [2](#Tab2){ref-type="table"} for more information on labeled cell types. Male and female mice were house together and female mice were checked daily for copulation plug. Once plug was confirmed, the potentially pregnant female was separated from the male and singly housed. On the day before the targeted gestation day, pregnant females were water deprived for 24 h. On the targeted gestation day, pregnant females were given 400 μL of water containing 30 μg/g of EdU (Abcam, ab146186) every 2 h for 12 h. Gestation day was confirmed when female gave birth on the 19th day. Table 2Genetic and Molecular Tools for Identifying ipRGC subtypes (in adult animals)Mouse Line/AntibodySubtype LabeledOther RGCs Labeled*Opn4-GFP*M1-M3None*Opn4* ^*Cre/+*^ *;ZEG*M1-M6None*Opn4* ^*LacZ/+*^M1NoneSMI-32M4 (ON sustained alpha)OFF sustained alpha and OFF transient alpha RGCsAnti-Brn3aNone\~ 70% of conventional RGCs

EdU mice of the correct genotype were dissected between 30 and 60 days of age. Mice were euthanized with CO~2~ asphyxiation, followed by cervical dislocation. Eyes were enucleated and retinas were fixed overnight in 4% PFA at 4 °C. The next day retinas were washed with PBS, blocked for 1 h at room temperature in 0.3% Triton-X, 6% goat or donkey serum and then placed into primary solution for 2--3 nights at 4 °C. Then retinas were washed with PBS and incubated in secondary solution for 2 h at room temperature. Finally, retinas were washed with PBS and click-it reaction was performed according to manufacturer's specifications on flat mounted retina (Thermo, C10640). After click-it reaction, retinas were washed with PBS and mounted in fluoromount. See Table [1](#Tab1){ref-type="table"} for specific antibodies and concentrations. 8 images were acquired at 0.5 mm, 1.0 mm, and 1.5 mm from the optic nerve for a total of 24 per retina. All images were captured using a confocal laser scanning microscope (LSM, DFC 310 FX, Leica) with a 40x oil-immersion objective.

Results {#Sec15}
=======

Morphological properties of ipRGC subtypes during development {#Sec16}
-------------------------------------------------------------

In order to assess the morphological and physiological properties of ipRGC subtypes during development, we first needed to confirm that we could reliably identify each subtype at early postnatal stages using criteria available to differentiate the adult subtypes. We chose to focus on M1, M2, and M4 ipRGCs because the properties of these subtypes are well characterized and they have been previously shown to tile the retina \[[@CR25]--[@CR27]\]. M1, M2, and M4 ipRGCs can be differentiated by their dendritic stratification in the inner plexiform layer (M1: OFF stratifying and M2, M4: ON stratifying) and by presence (M4) or absence (M1, M2) of SMI-32 immunolabeling. We therefore first wanted to determine whether we could identify ipRGC subtypes during postnatal development using these same criteria: M1 ipRGCs, OFF stratifying and SMI-32 negative, M2 ipRGCs, ON stratifying, SMI-32 negative, and M4 ipRGCs, ON stratifying, SMI-32 positive. We targeted ipRGCs in *Opn4-GFP* mice for patch clamp recordings of ipRGCs at P6, P8, P10, P14, and Adult ages and filled cells with neurobiotin. We then performed immunohistochemistry for SMI-32 and choline acetyltransferase (ChAT), determined whether each cell was SMI-32 positive and whether it was ON or OFF stratifying (using ChAT bands as a reference). Using the aforementioned subtyping criteria, we find that we can indeed clearly identify these three ipRGC subtypes in our earliest time point, P6 (Fig. [1](#Fig1){ref-type="fig"}). We therefore continued to use this method to categorize all ipRGCs going forward. Fig. 1M1, M2, and M4 subtypes can be identified using immunohistochemistry and dendritic stratification at P6. **a** M1 ipRGCs filled with neurobiotin (top panel) at P6 (left) and Adult (right) stages. Cells were immunolabeled for SMI-32 (blue, right panel). M1 ipRGCs are SMI-32 negative. Bottom panel: Orthogonal view of dendritic stratification from filled M1 cell (green; top panel) at P6 (left) and Adult (right). ChAT-positive amacrine cells are shown in magenta. **b** Dendritic depth measurements for M1 ipRGCs at P6 (yellow), P8 (light gray), P10 (dark gray), P14 (orange), and Adult (red) ages (*n* = 3 cells/age). **c** M2 ipRGCs filled with neurobiotin (top panel) at P6 (left) and Adult (right) stages. Cells were immunolabeled for SMI-32 (blue, right panel). M2 ipRGCs are SMI-32 negative. Bottom panel: Orthogonal view of dendritic stratification from filled M2 cell (green; top panel) at P6 (left) and Adult (right). ChAT-positive amacrine cells are shown in magenta. **d** Dendritic depth measurements for M2 ipRGCs at P6 (yellow), P8 (light gray), P10 (dark gray), P14 (orange), and Adult (red) ages (*n* = 3 cells/age). **e** M4 ipRGCs filled with neurobiotin (top panel) at P6 (left) and Adult (right) stages. Cells were immunolabeled for SMI-32 (blue, right panel). M4 ipRGCs are SMI-32 positive. Bottom panel: Orthogonal view of dendritic stratification from filled M4 cell (green; top panel) at P6 (left) and Adult (right). ChAT-positive amacrine cells are shown in magenta. **f** Dendritic depth measurements for M4 ipRGCs at P6 (yellow), P8 (light gray), P10 (dark gray), P14 (orange), and Adult (red) ages (*n* = 3 cells/age). White arrows point to soma. Light gray shading indicates OFF sublamina. ChAT: Choline Acetyltransferase. Ganglion cell layer (GCL) and inner nuclear layer (INL) refer to middle of respective cell body layer. Scale bar is 50 μm

Interestingly, when we mapped the lamination patterns of M1, M2, and M4 ipRGCs at P6 and adulthood, we found that all ipRGC subtypes had a different lamination pattern compared to their adult counterparts with the M1 subtype being most similar to adulthood (Fig. [1](#Fig1){ref-type="fig"}b). In contrast, the M2 and M4 subtypes seem to experience a bigger change in lamination pattern as cells mature. We observed that the M2 ipRGCs stratify closer to the middle of the IPL in early postnatal development before refining this dendritic lamination to the innermost portion of the IPL in adulthood (Fig. [1](#Fig1){ref-type="fig"}d) and that the M4 ipRGCs have dendrites stratifying closer to the ganglion cell layer in early postnatal development but then moving slightly closer to the middle of the IPL in adulthood (Fig. [1](#Fig1){ref-type="fig"}f), in agreement with previous observations of adult M2 and M4 ipRGC morphology \[[@CR28]\]. These findings suggest that although the M1, M2, and M4 ipRGC dendrites broadly stratify within the correct layer early on, their dendritic stratification undergoes refinement in later parts of postnatal development.

The ability to define ipRGC subtypes early in development affords us the opportunity to characterize the progression of ipRGC structural and functional development in a way that is not possible for most RGC types. By using SMI-32 and dendritic stratification we then went on to assess ipRGC subtypes morphology and physiology through development. We first analyzed the morphological changes that occur in each ipRGC subtype during postnatal development. To do this, we filled M1, M2, and M4 ipRGCs with Neurobiotin at P6, 8, 10, 14 and Adult stages. We measured soma size, dendritic field diameter, and total dendritic length, and performed Sholl analysis to assess the complexity of the dendritic arbors (Fig. [2](#Fig2){ref-type="fig"}). We found that soma size remained constant across development in M1 and M2 ipRGCs, but increased in M4 ipRGCs (Fig. [2](#Fig2){ref-type="fig"}h). With regards to dendritic field size, we found that M1 ipRGCs exhibit adult dendritic field size and length by P10 (Fig. [2](#Fig2){ref-type="fig"}c, d), while M2 ipRGCs mature by P14 (Fig. [2](#Fig2){ref-type="fig"}f, g) and M4 ipRGCs continuing to expand their dendritic field size and complexity beyond P14 (Fig. [2](#Fig2){ref-type="fig"}i, j). Fig. 2Dendritic length and diameter measurements for M1, M2, M4 subtypes during development. **a** Representative cell tracings of M1, M2, and M4 subtypes for P6, P8, P10, P14, Adult timepoints (*left*) and corresponding Sholl analysis for representative cells (*right*). **b**-**d** Mean ± SD M1 ipRGC soma diameter (**b**), dendritic field diameter (**c**), and total dendritic length (**d**). **e**-**g** Mean ± SD M2 ipRGC soma diameter (**e**), dendritic field diameter (**f**), and total dendritic length (**g**). **h**-**j** Mean ± SD M4 ipRGC soma diameter (**h**), dendritic field diameter (**i**), and total dendritic length (**j**). Scale bar is 50 μm, *n* = 5--8 per subtype/age,\**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001, \*\*\*\**p* \< 0.0001 when compared to Adult time point

In adulthood, M1 ipRGCs have the smallest somata and smallest, least complex dendritic arbors amongst these three subtypes while M4 ipRGCs have the largest somata, as well as the largest and most complex dendritic arbors \[[@CR1], [@CR25], [@CR28]\] (Fig. [3](#Fig3){ref-type="fig"}f). We therefore next examined whether the reported morphological differences between adult ipRGC subtypes could be detected at early postnatal stages (Fig. [3](#Fig3){ref-type="fig"}). Interestingly, at P6, we find that M1 ipRGCs have the largest dendritic field diameter while M4 ipRGCs have the smallest, which may be reflective of a faster rate of maturation for M1 ipRGC morphology (Fig. [3](#Fig3){ref-type="fig"}a). All three subtypes exhibit similar total dendritic length at this age while in adulthood M4 cells have the largest total dendritic length of the three subtypes (Fig. [3](#Fig3){ref-type="fig"}c, d). Of note, we found a large spread in the morphological measurements for the M1 and M4 subtypes the adult stage (Fig. [4](#Fig4){ref-type="fig"}), and so we did not find that the subtypes were significantly different in dendritic field diameter (Fig. [3](#Fig3){ref-type="fig"}b), as had been previously reported \[[@CR1], [@CR25], [@CR28]\]. The M4 variation is likely a function of the large differences in M4 ipRGC arbors from nasal, where M4 cells are very large, to temporal retina where M4 cells are very small \[[@CR29]\]. Additionally, M1 ipRGCs have been reported to show large variation in their morphological (and biophysical) properties \[[@CR30]\]. Sholl analyses comparing morphological complexity between all three subtypes reveals that the M2 and M4 ipRGCs begin to exhibit more complex dendritic arbors than M1 ipRGCs at early postnatal stages (Fig. [3](#Fig3){ref-type="fig"}e, f). Fig. 3Comparison of ipRGC subtype morphology at P6 and in Adulthood. **a**, **b** Mean ± SD dendritic field diameter at P6 (A) and Adult (B) for M1, M2, and M4 ipRGCs. **c**, **d** Mean ± SD total dendritic length at P6 (**c**) and Adult (**d**) for M1, M2, and M4 ipRGCs. **e**, **f** Mean ± SD number of crossings in Sholl analysis of M1, M2, and M4 ipRGCs at P8 (**e**) and Adult (**f**). *n* = 5--8 per subtype/age, \**p* \< 0.05, \*\**p* \< 0.01 Fig. 4M1 and M4 subtypes have large variation of morphology in adulthood*, Left,* Representative cell tracings of small and large Adult cells for the M1, M2, and M4 subtypes. *Right,* Average Sholl analysis for M1, M2, and M4 subtypes at P6, P8, P10, P14, and Adult. Graphs are Mean ± SD, *n* = 5--8 per subtype/age. Scalebar is 50 μm

Physiological properties of ipRGC subtypes during development {#Sec17}
-------------------------------------------------------------

Following morphological analysis, we next characterized the intrinsic physiological properties of M1, M2, and M4 ipRGCs across development. In general, the intrinsic physiological properties of each subtype were relatively stable across development (Fig. [5](#Fig5){ref-type="fig"}). We observed that M1 cells have a downward trend in capacitance and input resistance as cells age (Fig. [5](#Fig5){ref-type="fig"}c, d) while M2 and M4 cells experience a drop in capacitance between P14 and adult, as well as a downward trend in input resistance as development progresses (Fig. [5](#Fig5){ref-type="fig"}g, h, k, l). The variation in capacitance and resistance in particular are likely to be a combination of changes in membrane surface area, intrinsic membrane properties, and electrical coupling with a surrounding network of cells \[[@CR31]\]. When we directly compared the input resistance and resting membrane potential of M1, M2, and M4 ipRGC subtypes at P6 and Adult ages, we found that M1 cells have a more depolarized resting membrane potential and higher input resistance even early in development (Fig. [6](#Fig6){ref-type="fig"}a, c). These differences mimic those previously observed in light adapted tissue for adult M1 versus M2 and M4 ipRGCs \[[@CR20], [@CR32]\] as well as our own observations (Fig. [6](#Fig6){ref-type="fig"}b, d). Fig. 5Intrinsic physiological properties of ipRGC subtypes across development. (A-D) Mean ± SD M1 ipRGC resting membrane potential (**a**), spike frequency at rest (**b**), capacitance (**c**), and input resistance (**d**). (E-H) Mean ± SD M2 ipRGC resting membrane potential (**e**), spike frequency at rest (**f**), capacitance (**g**), and input resistance (**h**). **i**-**l** Mean ± SD M4 ipRGC resting membrane potential (**i**), spike frequency at rest (**j**), capacitance (**k**), and input resistance (**l**). n = 5--14 per subtype/age \**p* \< 0.05 when compared to Adult time point Fig. 6ipRGC subtypes exhibit distinct intrinsic properties from early postnatal development. (A-B) Mean ± SD resting membrane potential at P6 (**a**) and Adult (**b**) for M1, M2, and M4 ipRGCs. **c**, **d** Mean ± SD input resistance at P6 (**c**) and Adult (**d**) for M1, M2, and M4 ipRGCs. *n* = 5--14 per subtype/age, \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001

We next compared the spiking properties and action potential waveform of M1, M2, and M4 ipRGCs. We performed current clamp recordings from each of these subtypes and injected 1 s stepwise depolarizing current of 10 or 20pA until cells reached depolarization block. M1 ipRGCs show very few action potentials evoked by positive current (Fig. [7](#Fig7){ref-type="fig"}a, b), as reported previously for light-adapted M1 cells \[[@CR9], [@CR20]\]. In contrast, the M2 and M4 subtypes are much more excitable during development with the M4 subtype significantly increasing in excitability as cells mature (Fig. [7](#Fig7){ref-type="fig"}a, d, f). Somewhat surprisingly, the current density needed to reach the maximum spiking frequency was not significantly different across ages (Fig. [7](#Fig7){ref-type="fig"}c, e, g) for each of the subtypes. We next analyzed several components of individual action potentials from each subtype including width at half max, threshold, and fast after hyperpolarization (Fig. [8](#Fig8){ref-type="fig"}). Unsurprisingly, we find that action potential width at half-max decreases for all cell types across development (Fig. [8](#Fig8){ref-type="fig"}b, e, h) which is in line with typical progression of neuronal development \[[@CR33], [@CR34]\]. We also observe that threshold decreases for the M2 and M4 subtypes as cells mature (Fig. [8](#Fig8){ref-type="fig"}f, i). Fig. 7ipRGC subtype excitability across development. **a** Representative traces from depolarizing current injection that elicited the maximum spike output for M1, M2, and M4 subtypes at P6, P14, and Adult timepoints. **b**, **c** Maximum spike frequency elicited by depolarizing current steps (**b**) and maximum current density required to elicit maximum firing frequency (**c**) in M1 ipRGCs. **d**, **e** Maximum spike frequency elicited by depolarizing current steps (**d**) and maximum current density required to elicit maximum firing frequency (**e**) in M2 ipRGCs. **f**, **g** Maximum spike frequency elicited by depolarizing current steps (**f**) and maximum current density required to elicit maximum firing frequency (**g**) in M4 ipRGCs. Graphs are Mean ± SD, *n* = 5--14 per subtype/age, \**p* \< 0.05 when compared to Adult timepoint Fig. 8Action potential properties of ipRGC subtypes across development. **a** Representative traces of single action potentials for M1, M2, and M4 subtypes for P6 and Adult timepoints. (B-D) Measurement of M1 ipRGC AP full width at half max (**b**), AP threshold (**c**), and AP AHP (**d**). AP AHP P6 for M1 subtype is not plotted because cells did not hyperpolarize after action potential elicitation. (E-G) Measurement of M2 ipRGC AP full width at half max (**e**), AP threshold (**f**), and AP AHP (**g**). **h**-**j** Measurement of M4 ipRGC AP full width at half max (**h**), AP threshold (**i**), and AP AHP (**j**). Graphs are Mean ± SD, *n* = 5--14 per subtype/age, \**p* \< 0.05 when compared to Adult timepoint. AP: action potential, AHP: after hyperpolarization. Blue arrow indicates width at half-max, red dotted line indicates threshold, and black arrowhead indicates after hyperpolarization

In addition to the intrinsic properties of M1, M2, and M4 ipRGCs, we also examined the ipRGC light response across development. We performed current clamp recordings of ipRGC light responses to 30s of saturating blue light stimulus at 1 × 10^17^ photons/cm^2^ s^− 1^ at P6, P8, P10, P14, and Adult. In general, we found that all subtypes exhibited adult-like light responses by P14 (Fig. [9](#Fig9){ref-type="fig"}), consistent with the intact synaptic circuitry in the retina around the time of eye opening \[[@CR15], [@CR16]\]. Specifically, M2 and M4 ipRGCs, which are known to receive strong drive from the cone pathway \[[@CR1], [@CR28], [@CR35]\], show faster and larger light responses as development progress (Fig. [9](#Fig9){ref-type="fig"}d-g). M1 ipRGCs, however, had statistically similar light responses throughout development (Fig. [9](#Fig9){ref-type="fig"}b, c). This is in line with previous reports that M1 ipRGCs are strongly driven by melanopsin phototransduction in bright light \[[@CR35]\], and indicates that M1 ipRGCs show mature light responses from early developmental stages. M1 cells also showed strong depolarization block in their light responses, as reported previously \[[@CR36]\]. We note that there is a large variability in the light response for the M2 subtype at early developmental timepoints (Fig. [9](#Fig9){ref-type="fig"}a, d, e), which could mean that the M2 population is quite diverse earlier in development. This may reflect a difference between M2 cells that project to image and non-image forming visual regions, though this remains to be tested \[[@CR25]\]. Interestingly, when we compared ipRGC light responses early in development and adulthood, we observe that the maximum depolarization in response to light and onset time is statistically the same between all subtypes during development, although the M1 subtype tended to have a slightly larger depolarization and faster onset time on average (Fig. [10](#Fig10){ref-type="fig"}a, c). In adulthood, we see that again all subtypes have a similar maximum depolarization, however, the M1 subtype has the slowest onset time (Fig. [10](#Fig10){ref-type="fig"}b, d). Fig. 9ipRGCs light responses across development. **a** Representative light response traces from M1, M2, and M4 cells at P6, P8, P10, P14, and Adult timepoints. Blue rectangle indicates start and end of light stimulus. Black dotted line indicates − 65 mV. **b**, **c** M1 ipRGC maximum light response (**b**) and light onset (**c**). **d**, **e** M2 ipRGC maximum light response (**d**) and light onset (**e**). **f**, **g** M4 ipRGC maximum light response (**f**) and light onset (**g**). Light onset was defined by time to reach 50% of maximum depolarization. Graphs are Mean ± SD, *n* = 5--14 per subtype/age, \**p* \< 0.05, \*\**p* \< 0.01 when compared to Adult time point Fig. 10Comparison of light response properties of ipRGC subtypes across development. **a**, **b** Maximum light response of M1, M2, and M4 ipRGC subtypes at P6 (**a**) and Adult (**b**). **c**, **d** Light onset for M1, M2, and M4 ipRGC subtypes at P6 (**c**) and Adult (**d**). Light onset was defined by time to reach 50% of maximum depolarization. Graphs are Mean ± SD, *n* = 5--14 per subtype/age, \**p* \< 0.05

Assessing the embryonic birthdate of ipRGC subtypes {#Sec18}
---------------------------------------------------

Overall, our results suggest that ipRGC subtypes mature at different rates during postnatal development. We next asked whether these differences in maturation rate might be reflected in differences in cellular birthdate. That is, do the M1, M2, and M4 subtypes terminally differentiate at different embryonic timepoints, and how does this compare to the birthdate of conventional RGCs? To answer this, we utilized 5-ethynyl-2′-deoxyuridine (EdU), a thymidine analog, to label cells that terminally differentiated on specific embryonic days, also known as birthdating. We first compared the birthdate of all ipRGCs, M1--3 ipRGCs, and Brn3a-positive RGCs (non-ipRGCs). To do this, we quantified the percentage of cells that were EdU and GFP positive in both *Opn4*^*Cre/+*^*; Z/EG* animals (where all ipRGCs are labeled with GFP; Fig. [11](#Fig11){ref-type="fig"}a) and *Opn4*^*LacZ/+*^*; Opn4-GFP* animals (where only M1-M3 ipRGCs are labeled with GFP and only M1 ipRGCs are labeled with LacZ; Fig. [11](#Fig11){ref-type="fig"}a) from Embryonic Day E11--14. We also immunostained for a non-ipRGC population of RGC, the Brn3a-positive RGCs (Fig. [11](#Fig11){ref-type="fig"}a), and counted the number EdU-positive, Brn3a-positive RGCs from E11--14. While ipRGCs appear to be born primarily on E11 and E12 (Fig. [11](#Fig11){ref-type="fig"}b, c), we observed that Brn3a positive RGCs continued to terminally differentiate at E13 and E14, suggesting that ipRGC birthdates differ from other RGC types. Fig. 11ipRGCs are born earlier than Brn3a positive RGCs. **a**, *Top,* GFP or Brn3a immunohistochemistry (green) of retinas from Adult *Opn4*^*Cre/+*^*;ZEG*, *Opn4*^*LacZ/+*^*; Opn4-GFP* and *Opn4*^*Cre/+*^ animals exposed to EdU (magenta) at different developmental stages. White arrow heads point to examples cells co-labeled with GFP or Brn3a and EdU. *Bottom,* Schematic of cell types labeled green in each experiment. **b** Accumulation plot of proportion of ipRGCs or Brn3a RGCs that are EdU positive when exposed to EdU at different embryonic timepoints. Accumulation was calculated based on adding together the proportion data calculated for each timepoint. **c** Proportion of ipRGCs or Brn3a RGCs that are EdU positive when exposed to EdU on specific embryonic day. Graphs are Mean ± SD, *n* = 3--4 retinas per timepoint. Scale bar is 100 μm

We next wanted to assess and compare the birthdate of individual ipRGC subtypes (M1, M2/3, and M4 ipRGCs). To identify M4 ipRGCs from "non-M4" ipRGCs, we immunolabeled *Opn4*^*Cre/+*^*; Z/EG* retinas for SMI-32. M4 ipRGCs are easily identified as GFP positive, SMI-32 positive, while non-M4 ipRGCs are GFP positive, SMI-32 negative (Fig. [12](#Fig12){ref-type="fig"}b). In this line, OFF alpha RGCs can also be identified as GFP negative, SMI-32 positive. To differentiate M1 and M2/3 ipRGCs, we immunolabeled *Opn4*^*LacZ/+*^*; Opn4-GFP* mice for LacZ and GFP. M1 ipRGCs will be both GFP and LacZ positive (Fig. [12](#Fig12){ref-type="fig"}a), while M2/3 ipRGCs should be GFP positive, LacZ negative (though some M3 ipRGCs may be LacZ positive, see \[[@CR37]\]; Fig. [12](#Fig12){ref-type="fig"}a). In agreement with our broad comparisons in Fig. [11](#Fig11){ref-type="fig"}, we find that M1, M2, and M4 ipRGCs are all primarily born on E11 and E12 (Fig. [12](#Fig12){ref-type="fig"}c, d). Interestingly, when we compared the birthdate of M4/ON alpha RGCs and OFF alpha RGCs, we find that the OFF alpha RGCs continue to be born through E13 (Fig. [12](#Fig12){ref-type="fig"}e, f), highlighting an important difference in birthdate between the ON and OFF alpha RGC population, despite these cells being considered part of the same class of (alpha) RGC. Fig. 12ipRGC subtypes are born at the same rate and frequency. **a** *Top,* GFP (green) and LacZ (cyan) immunohistochemistry in Adult *Opn4*^*LacZ/+*^*; Opn4-GFP* retinas labeled for EdU (magenta). Yellow arrowheads point to EdU positive M1 cells (GFP+, LacZ+) and white arrows to EdU-positive M2 cells (GFP+, LacZ-). *Bottom,* Schematic of ipRGC subtypes labeled with each marker in experiment. **b** GFP (green) and SMI-32 (red) immunohistochemistry in Adult *Opn4*^*Cre/+*^*;ZEG* retinas labeled for EdU (magenta). Blue arrowheads indicate EdU-positive M4 cells (GFP+, SMI-32+), yellow arrows indicate EdU positive non-M4 ipRGCs (GFP+, SMI-32-), and grey arrowheads indicate EdU positive OFF-alpha RGCs (GFP-, SMI-32+). *Bottom,* Schematic of ipRGC subtypes labeled with each marker in experiment. **c** Accumulation plot of proportion of ipRGC subtypes that are EdU positive when exposed to EdU at different embryonic timepoints. Accumulation was calculated based on adding together the proportion data calculated for each timepoint. **d** Proportion of ipRGC subtypes that are EdU positive when exposed to EdU at specific embryonic timepoints. **e** Accumulation plot of proportion of M4 ipRGCs, non-M4 ipRGCs, and OFF alpha RGCs that are EdU positive when exposed to EdU at different embryonic timepoints. Accumulation was calculated based on adding together the proportion data calculated for each timepoint. **f** Proportion of M4 ipRGCs, non-M4 ipRGCs, and OFF alpha RGCs that are EdU positive when exposed to EdU at specific embryonic timepoints. Graphs are Mean ± SD, *n* = 3--4 retinas per timepoint. Scale bar is 100 μm

Discussion {#Sec19}
==========

ipRGCs are a diverse class of RGC that influence not only a wide range of visual behaviors, but also several important components of retinal development such as spontaneous retinal waves and pruning of retinal vasculature. While there have been several studies that have looked at ipRGCs during postnatal retinal development, only a few have distinguished amongst ipRGC subtypes. Understanding the properties of ipRGC subtypes throughout development, as we have done in this work, is a crucial first step in defining the mechanisms by which ipRGCs exert their many and varied influences on retinal and visual system development.

ipRGC subtypes are identifiable in early postnatal development via dendritic stratification and SMI-32 immunohistochemistry {#Sec20}
---------------------------------------------------------------------------------------------------------------------------

As with adult animals, we found that we were able to use dendritic stratification and SMI-32 to differentiate between M1, M2, and M4 ipRGCs. ipRGC stratification could be clearly identified at P6, and all of the ipRGCs in this dataset were clearly monostratified, even at P6. Moreover, SMI-32 immunolabeling was clearly evident in only a subset of ON-stratifying ipRGCs. One caveat of this approach is that we cannot be absolutely certain that the SMI-32 negative ipRGCs do not shift their dendrites from ON to OFF or OFF to ON as development progresses because we are unable to follow the development of single cells across time. However, all OFF ipRGCs exhibited properties and light responses that are consistent with M1 ipRGCs physiology \[[@CR20]\]. Moreover, none of the cells described here were bistratified, which is a transition state we would expect to observe regularly if stratification patterns shifted during development. These factors lead us to conclude that our method is likely able to correctly identify M1, M2, and M4 ipRGCs from early developmental stages.

M1 ipRGCs have the largest dendritic field during early postnatal development {#Sec21}
-----------------------------------------------------------------------------

In general, we observed that all subtypes have the same upward trend in dendritic field expansion and complexity across early postnatal development. Surprisingly, we found that in early development the M1 subtype had the largest dendritic field and M4 cells had the smallest, despite a reversal of these patterns in adulthood \[[@CR25], [@CR28]\]. However, we do find that in early development, like in adulthood, M1 cells have the least complex dendritic field (Fig. [3](#Fig3){ref-type="fig"}; \[[@CR20], [@CR25], [@CR28], [@CR38]\]). Overall, our data suggest that the M1 subtype reaches an adult morphology earlier than either M2 or M4 cells. This could be attributed to the fact that M1 dendrites most likely undergo less expansion and branching relative to the M2 and M4 subtypes.

Physiological properties are largely stable from early developmental stages {#Sec22}
---------------------------------------------------------------------------

Unlike with morphology, we see that most of the general rules for physiological differences between the subtypes in adult animals are also observed in early postnatal stages. For example, the adult M4 subtype has been shown to be more excitable than M1 and M2 cells \[[@CR9], [@CR20], [@CR32]\] and here we report that the M4 subtype is the most excitable among the three subtypes in both adulthood and during postnatal development (Fig. [7](#Fig7){ref-type="fig"}). We also find that, like in adulthood, the M1 subtype has the most depolarized resting membrane potential and largest input resistance among ipRGC subtypes during early postnatal development (Fig. [6](#Fig6){ref-type="fig"}; \[[@CR9], [@CR20], [@CR32]\]). While it is expected that physiological properties for ipRGC subtypes would be different from what has been reported in adulthood, it is interesting that the physiological differences between subtypes remains relatively consistent through development. These findings support the idea that different subtypes might be influencing different aspects of retinal development via unique signaling properties and physiological roles. One other interesting observation that we note is that both input resistance and capacitance decrease in all subtypes as cells mature, although it is more gradual in the M1 subtype relative the M2 and M4 subtypes (Fig. [5](#Fig5){ref-type="fig"}). Changes to capacitance and, to some extent, input resistance are indicative of changes in amount of cellular membrane surface area. Given that we observe an overall growth of the dendritic field and thus an increase in membrane for all subtypes, we would expect capacitance to increase as cells mature. The fact that we observe the exact opposite of this indicates that membrane space must be decreasing in some other way that we did not observe morphologically. One such way would be changes in electrical coupling between cells, which can influence capacitance and input resistance. In fact, it has been reported that ipRGCs during development are extensively coupled \[[@CR12], [@CR31]\]. While there has yet to be a study that directly looks at how coupling changes in ipRGC subtypes across development as well as how it differs between subtypes during development, it has been shown that M1 and M2 ipRGCs are coupled to GABAergic and ON displaced amacrine cells in adulthood \[[@CR38], [@CR39]\]. Similarly, adult M4 cells have been shown to couple amacrine cells \[[@CR40]\]. In contrast, work done by Arroyo et al., revealed that during development, ipRGCs are mostly connected to other retinal ganglion cells and other ipRGCs with low connectivity to GABAergic and other types of amacrine cells \[[@CR31]\]. They also showed that the number of cells that ipRGCs couple to 15 cells on average. In comparison, ipRGCs in adulthood have been found to couple to 5--25 cells with stark differences in number of cells coupled between subtypes \[[@CR38]\]. Taken together, this suggests that there is most likely a profound change in coupling between development and adulthood, a phenomenon that has been reported for ON-OFF direction-selective RGCs \[[@CR41]\]. Further work will need to be done to understand how the network changes as development progresses and if it changes different from subtype to subtype.

Diversity ipRGC light responses during development {#Sec23}
--------------------------------------------------

Multielectrode array recordings of light responses in P8 retinas were one of the first ways in which it was revealed that there are multiple subtypes of ipRGCs. Tu et al. found that there were three types during development based on light onset as defined by start of spike output: Type I, slow onset, sensitive, fast offset, Type II, slow onset, insensitive, slow offset, and Type III, rapid onset, sensitive, very slow offset \[[@CR13]\]. Follow up studies have suggested that adult M1 is type III \[[@CR20]\] and adult M2 is type II \[[@CR20]\] and adult M4 is type I \[[@CR14]\]. In complement to this, we used whole cell recording techniques to show that maximum depolarization is similar across subtypes at P8 and that when we define light onset by time to reach 50% of maximum light response, we find that M1 subtype (Type III) is still the fastest with the M2 (Type II) and M4 (Type I) subtypes having similar onset times (Fig. [10](#Fig10){ref-type="fig"}). Combined, this illustrates that while subtypes have similar maximum depolarizations in response to light, the kinetics of that response are actually very different. This diversity in kinetics and firing frequency gives rise to the very likely possibility that different subtypes might be modulating different developmental factors in response to light. However, it is not clear which components of the light response (firing frequency, spike latency, onset time of maximum response, or absolute maximum depolarization) are important determinants in modulating different aspects of retinal development in response to light and if the determining feature varies between light responsive developmental traits. Additionally, we recorded all light responses without synaptic blockers to measure the integrated light response of ipRGC subtypes, so it is not possible to separate melanopsin versus rod/cone signaling with our ipRGC recording paradigm. Currently, it seems to be that any or all of the ipRGC subtypes could be the modulators of retinal vasculature or the prolonging retinal waves in response to light. Genetic models that allow us to ablate single subtypes or abolish the melanopsin response within a particular subtype will help resolve the requirements of the melanopsin response as well as which subtypes are necessary for specific behaviors.

ipRGC birthdates diverge from conventional RGCs {#Sec24}
-----------------------------------------------

Previously, it had been reported that RGCs have different birthdates based on their ganglion cell classification \[[@CR42]\] and that Cdh3 positive RGCs which include a subset of the ipRGC population \[[@CR43]\] are born between E10 and E12. Furthermore, it has also been reported that the majority M1 ipRGCs are born between E11 and E12 \[[@CR44]\]. However, this study counted LacZ+ ipRGCs at P0, a time point at which other subtypes have been reported to express high amounts melanopsin \[[@CR14]\]. Thus, making it unclear if this was a purely M1 ipRGC population. Nonetheless, it is clear that some ipRGCs are born in the earlier part of retina cell type neurogenesis. Given the morphological and physiological differences within ipRGC subtypes (Figs. [3](#Fig3){ref-type="fig"} and [6](#Fig6){ref-type="fig"}; \[[@CR20], [@CR25], [@CR28]\]), we wondered whether non-M1 ipRGCs would also be born in the E11-E12 timeframe or if they would have different birthdates. Our results show that the majority of the M1, M2, and M4 ipRGC subtypes are born in within the E10-E12 timeframe and also reveal that M1, M2, and, M4 ipRGCs are all born at same rate (Fig. [12](#Fig12){ref-type="fig"}).

Our results also reveal that ipRGCs are born before Brn3a positive RGCs, thus revealing that RGC subtypes can vary in their birthdate, consistent with previous \[[@CR42], [@CR44]\]. However, this result is in contrast with a previous study of De la Huerta et al. in 2012 \[[@CR45]\] who showed that there was no difference in birthdate between RGC subtypes. We believe that one main contributing factor to this discrepancy is a difference in temporal resolution of our two studies. While we assessed birthdate at 1 day intervals, De la Huerta et al. used 2 or more. Additionally, this previous study used BrdU instead of EdU to label post-mitotic cells. Labeling with BrdU requires subsequent acid or heat shock to make the BrdU recognition site available for immunohistochemistry. Such harsh treatment could have altered antibody recognition sites for Brn3a. Lastly, the authors assessed cellular birthdates in retinal slices rather than whole mount like in this study. Altogether, this could have led to less cells counted over a longer interval period in comparison to this study which most likely led to large differences between our studies. More work to differentiate subsets of Brn3a positive cells will be an important avenue for future research.

The study done by Osterhout in 2014 also showed that the time at which an RGC is born can dictate the strategy the cell will employ in axon targeting. ipRGC subtypes each target very different brain regions, with M1 and some M2 ipRGCs targeting non-image forming targets and other M2 and M4 ipRGCs targeting image-forming brain regions \[[@CR25], [@CR26], [@CR46]\], indicating that RGCs with different downstream targets are also born at overlapping time points. Interestingly, we also observed that OFF alpha ganglion cells which share the alpha RGC classification with the M4 subtype, show distinctly different birthdating patterns from the ON alpha RGCs. It is possible that these temporal differences in differentiation underlie additional differences in ON versus OFF alpha RGC properties.

Conclusions {#Sec25}
===========

Because most RGC types are identified based on their adult characteristics, following distinct RGC types across development has proven difficult. ipRGCs early expression of melanopsin along with other identification markers provide us a unique opportunity to follow multiple RGC subtypes through development. Leveraging this advantage, we were able to carry out a broad characterization of ipRGC subtypes throughout the developmental timepoints at which they are influencing retinal and visual system development. This study lays the groundwork for future studies into the precise role of each ipRGC subtype in retinal development.

ChAT

:   Choline acetyltransferase

GCL

:   Ganglion cell layer

INL

:   Inner nuclear layer

IPL

:   Inner plexiform layer

ipRGC

:   Intrinsically photosensitive retinal ganglion cells

RGC

:   Retinal ganglion cells
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